Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.

Skip to main content

Table 1 Patients and primitive tumor characteristics (n = 184)

From: Changes in the characteristics of patients treated for brain metastases with repeat stereotactic radiotherapy (SRT): a retrospective study of 184 patients

Characteristics

Number

Percentage

Sex

Male

91

49.5

Female

93

50.5

Age at diagnosis of cancer

Median (range)

58 (21–87)

 

≤ 65 yo

135

73

> 65 yo

49

27

Age at diagnosis of brain metastasis

Median (range)

61 (24–88)

 

≤ 65 yo

124

67

> 65 yo

60

33

Primitive cancer

Lung

103

56.0

 Adenocarcinoma

69

67

 Epidermoid

19

18.4

 Small cell

4

3.9

 Undifferentiated

4

3.9

 Other

7

6.8

Breast

24

13.0

 Luminal A

5

20.8

 Luminal B

5

20.8

 Her2+

11

45.8

 Triple negative

3

12.5

Melanoma

24

13.0

Kidney

8

4.3

Digestive

16

8.7

Other

9

4.9

Initial tumor stage

1

23

12.5

2

47

25.5

3

38

20.7

4

30

16.3

Unknown

46

25.0

Initial node stage

0

37

20.1

1

23

12.5

2

49

26.6

3

26

14.1

Unknown

49

26.6

Initial metastasis stage

0

81

44.0

1

90

48.9

Unknown

13

7.1